Wall Street Associates’s AtriCure ATRC Stock Holding History

Wall Street Associates’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-51,695	Closed	-$1.16M	–	221
2015 Q4	$1.16M	Sell	51,695 -2,800	-5%	-$57.7K	0.33%	108
2015 Q3	$1.19M	Sell	54,495 -6,600	-11%	-$165K	0.23%	119
2015 Q2	$1.5M	Sell	61,095 -67,552	-53%	-$1.51M	0.14%	162
2015 Q1	$2.64M	Sell	128,647 -2,700	-2%	-$52.3K	0.25%	119
2014 Q4	$2.62M	Buy	131,347 +50	+0%	+$858	0.25%	123
2014 Q3	$1.93M	Sell	131,297 -25,500	-16%	-$406K	0.2%	140
2014 Q2	$2.88M	Sell	156,797 -18,600	-11%	-$310K	0.25%	126
2014 Q1	$3.3M	Hold	175,397	–	–	0.27%	124
2013 Q4	$3.28M	Sell	175,397 -12,670	-7%	-$184K	0.27%	123
2013 Q3	$2.06M	Sell	188,067 -1,892	-1%	-$18.6K	0.19%	154
2013 Q2	$1.8M	Buy	+189,959	New	+$1.65M	0.18%	152

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wall Street Associates's ATRC Position: Q1 2016 in Review

Wall Street Associates sold out of AtriCure (ATRC) in Q1 2016, closing a stake of 51,695 shares — an estimated $1.16M sold.

Wall Street Associates first reported a position in ATRC in Q2 2013 and held it in 11 quarters. The position peaked at $3.3M in Q1 2014. 113 funds tracked by Wall St. Rank hold ATRC as of Q1 2016.

Wall Street Associates reported no remaining AtriCure position as of Q1 2016 after selling out during the quarter.
Wall Street Associates sold 51,695 AtriCure shares in Q1 2016, an estimated $1.16M.
Wall Street Associates first reported a position in AtriCure in Q2 2013 and held it in 11 quarters.
Wall Street Associates's AtriCure position peaked at $3.3M in Q1 2014.
113 funds tracked by Wall St. Rank held AtriCure as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.